Centre of Expertise Urban Vitality
B. Valentin (Bas)
Telephone:
- 0643153029
Email:
- b.valentin@hva.nl
Work address:
-
Dr. Meurerhuis, Dokter Meurerlaan 8, 1067 SM Amsterdam
Postal address:
- Postbus 2165,1000 CD Amsterdam
Room number:
- B.128
Personal website:
Bas Valentin is onderzoeker bij het lectoraat Voeding en Beweging. Hij is betrokken bij het LEEV!-project en onderzoekt de effecten van een gepersonaliseerde leefstijlinterventie voor volwassenen met een verstandelijke beperking.
In 2018 studeerde Bas af aan de opleiding Voeding en Diëtetiek. Daarna behaalde hij de master Klinische Epidemiologie aan de Universiteit van Amsterdam.
-
Lifestyle interventions improve muscle function, fat mass, muscle mass and the sarcopenic obesity index
Reijnierse, E. M., Valentin, B., Benz, E., Pinel, A., Boirie, Y., Memelink, R. G., Weijs, P. J. M., Verlaan, G., & Schoufour, J. D. (2024). Lifestyle interventions improve muscle function, fat mass, muscle mass and the sarcopenic obesity index. 1002. https://doi.org/10.1016/j.clnesp.2024.07.127
-
The prevalence of sarcopenic obesity in older adults with obesity differs between the use of the chair stand test and handgrip strength as measure of altered muscle function
Valentin, B., Reijnierse, E. M., Memelink, R. G., Weijs, P. J. M., Verlaan, G., & Schoufour, J. D. (2024). The prevalence of sarcopenic obesity in older adults with obesity differs between the use of the chair stand test and handgrip strength as measure of altered muscle function. 1095. https://doi.org/10.1016/j.clnesp.2024.07.368
-
Sarcopenia predicts 5-year mortality in older adults with intellectual disabilities
Valentin, B., Maes-Festen, D., Schoufour, J., & Oppewal, A. (2023). Sarcopenia predicts 5-year mortality in older adults with intellectual disabilities. Journal of Intellectual Disability Research, 67(11), 1161-1173. https://doi.org/10.1111/jir.13078
-
2Do
Boerdijk, L., Memelink, R., & Valentin, B. (2022). 2Do: intensieve leefstijlinterventie voor ouderen met overgewicht/obesitas en type 2 diabetes/prediabetes. Web publication or website, Rijksinstituut voor Volksgezondheid en Milieu. https://www.loketgezondleven.nl/interventies-zoeken#/InterventionDetails/2100113
-
Sustained changes in body composition during 6 months follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes
Memelink, RG., Pasman, WJ., Valentin, B., de Vogel - van den Bosch, J., & Weijs, PJM. (2019). Sustained changes in body composition during 6 months follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes. Poster session presented at 13th edition Science Exchange Day , Amsterdam, Netherlands.
-
Sustained changes in body composition during 6 months follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes
Memelink, RG., Pasman, WJ., Valentin, B., de Vogel - van den Bosch, J., & Weijs, PJM. (2019). Sustained changes in body composition during 6 months follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes. Poster session presented at 37th International Symposium on Diabetes & Nutrition, Kerkrade, Netherlands.
-
Sustained body composition change during 6-month follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes
Memelink, RG., Pasman, WJ., Valentin, B., de Vogel-van den Bosch, J., & Weijs, PJM. (2019). Sustained body composition change during 6-month follow-up after combined lifestyle intervention in older adults with obesity and type 2 diabetes. Poster session presented at EFAD conference, Berlin, Germany.
-
Effectiveness of a combined lifestyle intervention using dietary counselling and resistance exercise in obese older adults with type 2 diabetes (the PROBE study)
Valentin, B., Vu, V., Tump, A., van Rijmenam, M., Schuurman, C., Pasman, W., de Vogel-van den Bosch, J., van Ginkel, A., Memelink, R., & Weijs, P. (2018). Effectiveness of a combined lifestyle intervention using dietary counselling and resistance exercise in obese older adults with type 2 diabetes (the PROBE study). Poster session presented at EFAD Conference 2018, Rotterdam, Netherlands.